Trademarks = 2

Forward Citations = 1,314

Loading Chart...

6 inventors (with patents filed for the assignee):

Shu-Tung Li (7 out of 44 patents)

Kevin R Stone (4 out of 56 patents)

J Richard Steadman (2 out of 2 patents)

4. William G Rodkey (1 out of 1 patent)

5. Jack A McCarthy (1 out of 1 patent)

6. Vincent P Novak (1 out of 1 patent)

8 patents: Sort by Forward Citations

1. 6350274 - Soft tissue closure systems (2002-02-26),

2. 6042610 - Meniscal augmentation device (2000-03-28),

3. 5928252 - Device and method for driving a needle and meniscal repair (1999-07-27),

4. 5735902 - Hand implant device (1998-04-07),

5. 5681353 - Meniscal augmentation device (1997-10-28),

6. 5677284 - Charged collagen particle-based delivery matrix (1997-10-14),

7. 5624463 - Prosthetic articular cartilage (1997-04-29),

8. 5263984 - Prosthetic ligaments (1993-11-23),

Company Overview

Regen Biologics, Inc. is a biotechnology company focused on developing innovative regenerative medicine solutions for musculoskeletal and wound care applications. With a strong emphasis on research and development, the company aims to deliver cutting-edge therapies that improve patient outcomes and quality of life.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

8 Patents

#55 in Oakland, CA

#8,540 in California

#35,924 in US

Oakland, CA, United States of America

Regen Biologics, Inc.

Forward Citations = 1,314

6 inventors:

Shu-Tung Li (7 out of 44 patents)

Kevin R Stone (4 out of 56 patents)

J Richard Steadman (2 out of 2 patents)

4. William G Rodkey (1 out of 1 patent)

5. Jack A McCarthy (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Regen Biologics, Inc.. Retrieved from https://idiyas.com/company/regen-biologics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]